Table 3. Treatment-related AEs.
| AE | Incidence, n (%) |
|||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Afebrile neutropenia | 9 (30.0) | 4 (13.3) | 5 (16.7) | 0 (0.0) |
| Febrile neutropenia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Anemia | 3 (10.0) | 2 (6.7) | 0 (0.0) | 0 (0.0) |
| Thrombocytopenia | 4 (13.3) | 2 (6.7) | 0 (0.0) | 0 (0.0) |
| Alopecia | 8 (26.7) | 16 (53.3) | – | – |
| Fatigue | 6(20.0) | 5 (16.7) | 0 (0.0) | 0 (0.0) |
| Hand-foot syndrome | 3 (10.0) | 2 (6.7) | 4 (13.3) | 0 (0.0) |
| Peripheral neuropathy | 6 (20.0) | 10 (33.3) | 7 (23.3) | 0 (0.0) |
| Phototoxic skin reaction | 0 (0.0) | 2 (6.7) | 3 (10.0) | 0 (0.0) |
| Anorexia | 4 (13.3) | 1 (3.3) | 0 (0.0) | 0 (0.0) |
| Nausea/vomiting | 4 (13.3) | 1 (3.3) | 0 (0.0) | 0 (0.0) |
| Stomatitis | 2 (6.7) | 2 (6.7) | 0 (0.0) | 0 (0.0) |
| Constipation | 0 (0.0) | 2 (6.7) | 0 (0.0) | 0 (0.0) |
| Diarrhoea | 7 (23.3) | 3 (10.0) | 0 (0.0) | 0 (0.0) |
AEs, adverse events.